AAN GUIDELINES Bundle

Cluster Headache

AAN GUIDELINES Product Bundle brought to you by Guideline Central.

Issue link: https://eguideline.guidelinecentral.com/i/322482

Contents of this Issue

Navigation

Page 5 of 5

Disclaimer is Guideline reproduction is based on an assessment of current scientific and clinical information. It is not intended to include all possible proper methods of care for a particular neurologic problem or all legitimate criteria for choosing to use a specific procedure. It is also not intended to exclude any reasonable alternative methodologies. Specific patient care decisions are the prerogative of the patient and the physician caring for the patient, based on all of the circumstances involved. is Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. See published guideline for complete text. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Source Francis GJ, Becker WJ, Pringsheim TM. Acute and preventive pharmacologic treatment of cluster headache. Neurolog y. 2010;75(5):463-473. 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 For additional copies: info@GuidelineCentral.com Copyright © 2012 All rights reserved Classification of Management Recommendations Classification Definition Strong (A) Established as effective, ineffective, or harmful (or established as useful/ predictive or not useful/predictive) for the given condition in the specified population. (Level A rating requires at least two consistent Class I studies.)* Moderate (B) Probably effective, ineffective, or harmful (or probably useful/predictive or not useful/predictive) for the given condition in the specified population. (Level B rating requires at least one Class I study or two consistent Class II studies.) Weak (C) Possibly effective, ineffective, or harmful (or possibly useful/predictive or not useful/predictive) for the given condition in the specified population. (Level C rating requires at least one Class II study or two consistent Class III studies.) Insufficient (U) Data inadequate or conflicting ; given current knowledge, treatment (test, predictor) is unproven. * In exceptional cases, one convincing Class I study may suffice for an "A" recommendation if 1) all criteria are met, 2) the magnitude of effect is large (relative rate improved outcome is greater than 5 and the lower limit of the confidence interval is greater than 2). CLU011210

Articles in this issue

Links on this page

view archives of AAN GUIDELINES Bundle - Cluster Headache